natgillin/translations-raw huggingface dataset:
Telzir with low doses of ritonavir is used in combination with other anti-retroviral medicines (‘combination therapy’) to treat adults, adolescents and children aged over 6 years infected with HIV.
Zdravilo Telzir z nizkimi odmerki ritonavirja uporabljamo v kombinaciji z drugimi protiretrovirusnimi zdravili (‘kombinirano zdravljenje’) za zdravljenje okužbe z virusom HIV pri odraslih, mladostnikih in otrocih, starejših od 6 let.
Telzir with ritonavir is not recommended in children below 6 years due to insufficient data on pharmacokinetics, safety and antiviral response (see section 5.2).
zdravilo Telzir v kombinaciji z ritonavirjem zaradi pomanjkljivih podatkov o farmakokinetiki, varnosti in in protivirusnemu odzivu ni priporočljiv za otroke, mlajše od 6 let (glejte poglavje 5.2).
Telzir with ritonavir must not be co-administered with medicinal products with narrow therapeutic windows that are highly dependent on CYP2D6 metabolism e.g. flecainide and propafenone (see section 4.5).
Zdravilo Telzir v kombinaciji z ritonavirjem se ne sme uporabljati sočasno z zdravili ozke terapevtske širine, ki so pri svoji presnovi zelo odvisni od CYP2D6, npr. s flekainidom in propafenonom (glejte poglavje 4.5).
Telzir with ritonavir should be used with caution and at reduced doses in adults with mild, moderate or severe hepatic impairment (see section 4.2).
Pri odraslih z blago, zmerno ali hudo jetrno okvaro je treba zdravilo Telzir v kombinaciji z ritonavirjem uporabljati previdno in odmerka zmanjšati (glejte poglavje 4.2).
Telzir with ritonavir should be used with caution and at reduced doses in adults with mild, moderate, or severe hepatic impairment (see section 4.2).
Pri odraslih z blago, zmerno ali hudo jetrno okvaro je treba zdravilo Telzir v kombinaciji z ritonavirjem uporabljati previdno in odmerke zmanjšati (glejte poglavje 4.2).
Telzir, taken in combination with other antiviral medicines, has also been assessed in one main study including 57 HIV-infected patients aged between two and 18 years.
Zdravilo Telzir v kombinaciji z drugimi protivirusnimi zdravili je bilo ocenjeno tudi v eni glavni študiji, v katero je bilo vključenih 57 bolnikov, okuženih z virusom HIV, starih od dveh do 18 let.
Telzir, taken in combination with other antiviral medicines, reduces the amount of HIV in the blood and keeps it at a low level.
Zdravilo Telzir v kombinaciji z drugimi protivirusnimi zdravili zmanjša količino virusa HIV v krvi in ga ohranja na nizki ravni.
Temodal 2.5 mg/ml powder for solution for infusion may be administered in the same IV line with 0.9% Sodium Chloride injection.
Zdravilo Temodal 2,5 mg/ml prašek za raztopino za infundiranje se sme dajati v isto intravensko linijo z injekcijo 0,9 % natrijevega klorida.
Temodal 250 mg hard capsules: gelatin, titanium dioxide (E 171), sodium lauril sulfate. printing ink: shellac, propylene glycol, purified water, ammonium hydroxide, potassium hydroxide, and black iron oxide (E 172).
Temodal 250 mg trde kapsule: želatina, titanov dioksid (E 171), natrijev lavrilsulfat. črnilo tiska: šelak, propilenglikol, prečiščena voda, amonijev hidroksid, kalijev hidroksid in črni železov oksid (E 172).
Temodal 5 mg hard capsules Temodal 20 mg hard capsules Temodal 100 mg hard capsules Temodal 140 mg hard capsules Temodal 180 mg hard capsules Temodal 250 mg hard capsules temozolomide
Temodal 5 mg trde kapsule Temodal 20 mg trde kapsule Temodal 100 mg trde kapsule Temodal 140 mg trde kapsule Temodal 180 mg trde kapsule Temodal 250 mg trde kapsule temozolomid (temozolomidum)
Temodal contains a medicine called temozolomide.
Zdravilo Temodal vsebuje zdravilno učinkovino temozolomid.
Temodal in combination treatment with radiotherapy in newly-diagnosed glioblastoma
Zdravilo Temodal pri kombiniranem zdravljenju z radioterapijo pri novo diagnosticiranem glioblastomu
Temodal is administered in combination with focal radiotherapy (concomitant phase) followed by up to 6 cycles of temozolomide (TMZ) monotherapy (monotherapy phase).
Zdravilo Temodal se uporablja v kombinaciji z žariščno radioterapijo (faza sočasne terapije), temu pa sledi do 6 ciklov monoterapije (monoterapijska faza) s temozolomidom (TMZ).
Temodal is first used together with
Zdravilo Temodal se najprej
Temodal is indicated for the treatment of: adult patients with newly-diagnosed glioblastoma multiforme concomitantly with radiotherapy (RT) and subsequently as monotherapy treatment. children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
Zdravilo Temodal je indicirano za zdravljenje: odraslih bolnikov z novo diagnosticiranim multiformnim glioblastomom, sočasno z radioterapijo (RT) in pozneje kot monoterapija otrok, starih 3 leta in več, mladostnikov in odraslih bolnikov z malignim gliomom, na primer multiformnim glioblastomom ali anaplastičnim astrocitomom, ki se po standardnem zdravljenju ponovi ali napreduje.
Temodal is indicated for the treatment of: adult patients with newly-diagnosed glioblastoma multiforme concomitantly with radiotherapy (RT) and subsequently as monotherapy treatment. children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
Zdravilo Temodal je indicirano za zdravljenje: odraslih bolnikov z novo diagnosticiranim multiformnim glioblastomom, sočasno z radioterapijo (RT) in pozneje kot monoterapija otrok, starih 3 leta in več, mladostnikov in odraslih bolnikov z malignimi gliomi, npr. multiformnimi glioblastomi ali anaplastičnimi astrocitomi, ki se po standardnem zdravljenju ponovijo ali napredujejo.
Temodal is used first with radiotherapy and then on its own; adults and children three years of age and over with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, when the tumour has returned or got worse after standard treatment.
Zdravilo Temodal se najprej uporabi v kombinaciji z obsevanjem, nato pa kot samostojno zdravilo; odraslih in otrok, starih tri leta in več, z malignim gliomom, kakršna sta multiformni glioblastom ali anaplastični astrocitom, če se je tumor po standardnem zdravljenju ponovil ali poslabšal.
Temodal is used for the treatment of specific forms of brain tumours: in adults with newly-diagnosed glioblastoma multiforme.
Zdravilo Temodal se uporablja za zdravljenje določenih vrst možganskih tumorjev: pri odraslih z novo diagnosticiranim multiformnim glioblastomom.
Temodal may make you feel tired or sleepy.
Med jemanjem zdravila Temodal boste morda utrujeni ali zaspani.
Temodal may make you feel tired or sleepy.
Med uporabo zdravila Temodal boste morda utrujeni ali zaspani.
Temodal monotherapy in recurrent or progressive glioma
Samostojno zdravljenje z zdravilom Temodal pri ponavljajočem se ali napredujočem gliomu
Temomedac 100 mg
Temomedac 100 mg trde kapsule
Temomedac 100 mg hard capsules
Temomedac 100 mg trde kapsule
Temomedac 100 mg hard capsules temozolomide
Temomedac 100 mg trde kapsule temozolomid
Temomedac 100 mg hard capsules: Each capsule contains 100 mg temozolomide.
Temomedac 100 mg trde kapsule: ena kapsula vsebuje100 mg temozolomida.
Temomedac 100 mg hard capsules: gelatin, titanium dioxide (E 171), red iron oxide (E 172), shellac, propylene glycol and yellow iron oxide (E 172).
Temomedac 100 mg trde kapsule: želatina, titanov dioksid (E 171), rdeči železni oksid (E 172) šelak, propilenglikol, rumeni železov oksid (E 172),
Temomedac 140 mg
Temomedac 140 mg trde kapsule
Temomedac 140 mg hard capsules
Temomedac 140 mg trde kapsule
Temomedac 140 mg hard capsules temozolomide
Temomedac 140 mg trde kapsule temozolomid
Temomedac 140 mg hard capsules: Each capsule contains 140 mg temozolomide.
Temomedac 140 mg trde kapsule: ena kapsula vsebuje 140 mg temozolomida.
Temomedac 140 mg hard capsules: gelatin, titanium dioxide (E 171), shellac, propylene glycol, indigo carmine (E 132) aluminium lake.
Temomedac 140 mg trde kapsule: želatina, titanov dioksid (E 171), šelak, propilenglikol, indigo karmin (E 132) aluminijevo rdeče,
Temomedac 180 mg
Temomedac 180 mg trde kapsule
Temomedac 180 mg hard capsules
Temomedac 180 mg trde kapsule
Temomedac 180 mg hard capsules temozolomide
Temomedac 180 mg trde kapsule temozolomid
Temomedac 180 mg hard capsules: Each capsule contains 180 mg temozolomide.
Temomedac 180 mg trde kapsule: ena kapsula vsebuje 180 mg temozolomida.
Temomedac 180 mg hard capsules: gelatin, titanium dioxide (E 171), shellac, propylene glycol, red iron oxide (E 172)
Temomedac 180 mg trde kapsule: želatina, titanov dioksid (E 171), šelak, propilenglikol, rdeči železov oksid (E 172),
Temomedac 20 mg
Temomedac 20 mg trde kapsule
Temomedac 20 mg hard capsules
Temomedac 20 mg trde kapsule
Temomedac 20 mg hard capsules temozolomide
Temomedac 20 mg trde kapsule temozolomid
Temomedac 20 mg hard capsules: Each capsule contains 20 mg temozolomide.
Temomedac 20 mg trde kapsule: ena kapsula vsebuje 20 mg temozolomida.
Temomedac 20 mg hard capsules: gelatine, titanium dioxide (E 171), shellac, propylene glycol, sunset yellow FCF aluminium Lake (E 110).
Temomedac 20 mg trde kapsule: želatina, titanov dioksid (E 171), šelak, propilenglikol, oranžno FCF aluminijevo rdeče (E 110),
Temomedac 250 mg
Temomedac 250 mg trde kapsule
Temomedac 250 mg hard capsules
Temomedac 250 mg trde kapsule
Temomedac 250 mg hard capsules temozolomide
Temomedac 250 mg trde kapsule temozolomid
Temomedac 250 mg hard capsules: Each capsule contains 250 mg temozolomide.
Temomedac 250 mg trde kapsule: ena kapsula vsebuje 250 mg temozolomida.
Temomedac 250 mg hard capsules: gelatin, titanium dioxide (E 171), shellac, propylene glycol, black iron oxide (E 172).
Temomedac 250 mg trde kapsule: želatina, titanov dioksid (E 171), šelak, propilenglikol črni železov oksid (E 172).
Temomedac 5 mg
Temomedac 5 mg trde kapsule
Temomedac 5 mg hard capsules
Temomedac 5 mg trde kapsule
Temomedac 5 mg hard capsules Temomedac 20 mg hard capsules Temomedac 100 mg hard capsules Temomedac 140 mg hard capsules Temomedac 180 mg hard capsules Temomedac 250 mg hard capsules
Temomedac 5 mg trde kapsule Temomedac 20 mg trde kapsule Temomedac 100 mg trde kapsule Temomedac 140 mg trde kapsule Temomedac 180 mg trde kapsule Temomedac 250 mg trde kapsule
Temomedac 5 mg hard capsules temozolomide
Temomedac 5 mg trde kapsule temozolomid
Temomedac 5 mg hard capsules: Each capsule contains 5 mg temozolomide.
Temomedac 5 mg trde kapsule: ena kapsula vsebuje 5 mg temozolomida.
Temomedac 5 mg hard capsules: gelatin, titanium dioxide (E 171), shellac, propylene glycol, indigo carmine (E 132) aluminium lake, yellow iron oxide (E 172)
Temomedac 5 mg trde kapsule: želatina, titanov dioksid (E 171), šelak, propilenglikol , indigo karmin (E 132) aluminijevo rdeče, rumeni železov oksid (E 172),
Temomedac contains a medicine called temozolomide.
Zdravilo Temomedac vsebuje zdravilno učinkovino temozolomid.
Temomedac contains lactose
Zdravilo Temomedac vsebuje laktozo
Temomedac contains lactose (a kind of sugar).
Zdravilo Temomedac vsebuje laktozo (vrsta sladkorja).
Temomedac hard capsules should be administered in the fasting state.
Temomedac trde kapsule mora bolnik jemati na tešče.
Temomedac in combination treatment with radiotherapy in newly-diagnosed glioblastoma
Zdravilo Temomedac pri kombiniranem zdravljenju z radioterapijo pri novo diagnosticiranem glioblastomu
Temomedac is a ‘generic medicine’.
Zdravilo Temomedac je „generično zdravilo“.
Temomedac is administered in combination with focal radiotherapy (concomitant phase) followed by up to 6 cycles of temozolomide (TMZ) monotherapy (monotherapy phase).
Zdravilo Temomedac se uporablja v kombinaciji z žariščno radioterapijo (faza sočasne terapije), temu pa sledi do 6 ciklov monoterapije (monoterapijska faza) s temozolomidom (TMZ).
Temomedac is first used together with
Zdravilo Temomedac se
Temomedac is indicated for the treatment of: adult patients with newly-diagnosed glioblastoma multiforme concomitantly with radiotherapy (RT) and subsequently as monotherapy treatment. children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
Zdravilo Temomedac je indicirano za zdravljenje: odraslih bolnikov z novo diagnosticiranim multiformnim glioblastomom, sočasno z radioterapijo (RT) in pozneje kot monoterapija otrok, starih 3 leta in več, mladostnikov in odraslih bolnikov z malignim gliomom, na primer multiformnim glioblastomom ali anaplastičnim astrocitomom, ki se po standardnem zdravljenju ponovi ali napreduje.
Temomedac is used first with radiotherapy and then on its own; adults and children three years of age and over with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, when the tumour has returned or got worse after standard treatment.
Zdravilo Temomedac se najprej uporabi skupaj z radioterapijo, nato pa samostojno; odraslih in otrok, starejših od treh let, z malignim gliomom, kakršna sta multiformni glioblastom ali anaplastični astrocitom, če se je tumor po standardnem zdravljenju ponovil ali poslabšal.
Temomedac is used for the treatment of specific forms of brain tumours: in adults with newly-diagnosed glioblastoma multiforme.
Zdravilo Temomedac se uporablja za zdravljenje določenih vrst možganskih tumorjev: pri odraslih z novo diagnosticiranim multiformnim glioblastomom.
Temomedac is used in these tumours if they return or get worse after standard treatment.
Zdravilo Temomedac se pri teh tumorjih uporablja, če se po standardnem zdravljenju ponovijo ali poslabšajo.
Temomedac may cause permanent infertility.
Zdravilo Temomedac lahko povzroči trajno neplodnost.
Temomedac may make you feel tired or sleepy.
Med jemanjem zdravila Temomedac boste morda utrujeni ali zaspani.
Temomedac monotherapy in recurrent or progressive glioma
Samostojno zdravljenje z zdravilom Temomedac pri ponavljajočem se ali napredujočem gliomu
Temomedac should not be administered to pregnant women.
Zdravila Temomedac se ne sme dajati nosečnicam.
Temomedac should only be prescribed by physicians experienced in the oncological treatment of brain tumours.
Zdravilo Temomedac smejo predpisati le zdravniki, ki imajo izkušnje z zdravljenjem možganskih tumorjev.
Temomedac treatment can cause a reduction in certain kinds of blood cells.
Zdravljenje z zdravilom Temomedac lahko povzroči zmanjšanje števila določenih vrst krvnih celic.
Temozolomide Accord 100 mg hard capsules have a white body, a pink cap, and are imprinted ‘TMZ’ on cap and ‘100’ on body with black ink.
Temozolomid Accord 100 mg trde kapsule zdravila Temozolomid Accord so bele z roza kapico, potiskane pa so s črnim črnilom z oznako 'TMZ' na kapici in oznako '100' na telesu.
Temozolomide Accord 100 mg hard capsules.
Temozolomid Accord 100 mg trde kapsule
Temozolomide Accord 140 mg hard capsules have a white body, a blue cap, and are imprinted ‘TMZ’ on cap and ‘140’ on body with black ink.
Temozolomid Accord 140 mg trde kapsule zdravila Temozolomid Accord so bele z modro kapico, potiskane pa so s črnim črnilom z oznako 'TMZ' na kapici in oznako '140' na telesu.
Temozolomide Accord 140 mg hard capsules.
Temozolomid Accord 140 mg trde kapsule
Temozolomide Accord 180 mg hard capsules have a white body, a maroon cap, and are imprinted ‘TMZ’ on cap and ‘180’ on body with black ink.
Temozolomid Accord 180 mg trde kapsule zdravila Temozolomid Accord so bele z rjavo kapico, potiskane pa so s črnim črnilom z oznako 'TMZ' na kapici in oznako '180' na telesu.
Temozolomide Accord 180 mg hard capsules.
Temozolomid Accord 180 mg trde kapsule
Temozolomide Accord 20 mg hard capsules have a white body, a yellow cap, and are imprinted ‘TMZ’ on cap and ‘20’ on body with black ink.
Temozolomid Accord 20 mg trde kapsule zdravila Temozolomid Accord so bele z rumeno kapico, potiskane pa so s črnim črnilom z oznako 'TMZ' na kapici in oznako '20' na telesu.
Temozolomide Accord 20 mg hard capsules.
Temozolomid Accord 20 mg trde kapsule
Temozolomide Accord 250 mg hard capsules have a white body, a white cap, and are imprinted ‘TMZ’ on cap and ‘250’ on body with black ink.
Temozolomid Accord 250 mg trde kapsule zdravila Temozolomid Accord so bele z belo kapico, potiskane pa so s črnim črnilom z oznako 'TMZ' na kapici in oznako '250' na telesu.
Temozolomide Accord 250 mg hard capsules temozolomide
Temozolomid Accord 250 mg trde kapsule temozolomid
Temozolomide Accord 250 mg hard capsules.
Temozolomid Accord 250 mg trde kapsule
Temozolomide Accord 5 mg hard capsules have a white body, a green cap, and are imprinted ‘TMZ’ on cap and ‘5’ on body with black ink.
Temozolomid Accord 5 mg trde kapsule zdravila Temozolomid Accord so bele z zeleno kapico, potiskane pa so s črnim črnilom z oznako 'TMZ' na kapici in oznako '5' na telesu.
Temozolomide Accord 5 mg hard capsules temozolomide
Temozolomid Accord 5 mg trde kapsule temozolomid
Temozolomide Accord 5 mg hard capsules.
Temozolomid Accord 5 mg trde kapsule,
Temozolomide Accord is a ‘generic medicine’.
Temozolomide Accord je „generično zdravilo“.
Temozolomide Accord is administered in combination with focal radiotherapy (concomitant phase) followed by up to 6 cycles of temozolomide (TMZ) monotherapy (monotherapy phase).
Zdravilo Temozolomid Hopsira se uporablja v kombinaciji s fokalno radioterapijo (faza sočasnega zdravljenja), čemur sledi do 6 ciklov monoterapije s temozolomidom (TMZ) - faza monoterapije.
Temozolomide Accord is indicated for the treatment of: adult patients with newly-diagnosed glioblastoma multiforme concomitantly with radiotherapy (RT) and subsequently as monotherapy treatment. children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
Zdravilo Temozolomid Accord je indicirano za zdravljenje: odraslih bolnikov z novo diagnosticiranim multiformnim glioblastomom ob sočasni radioterapiji (RT) in nato kot monoterapija. otrok, starejših od treh let, mladostnikov in odraslih bolnikov z malignim gliomom, na primer multiformnim glioblastomom ali anaplastičnim astrocitomom, ki se po standardnem zdravljenju ponovi ali napreduje.
Temozolomide Accord is used first with radiotherapy and then on its own; adults and children three years of age and over with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, when the tumour has returned or got worse after standard treatment.
Zdravilo Temozolomide Accord se najprej uporabi skupaj z radioterapijo, nato pa samostojno; odraslih in otrok, starejših od treh let, z malignim gliomom, kakršna sta multiformni glioblastom ali anaplastični astrocitom, če se je tumor po standardnem zdravljenju ponovil ali poslabšal.
Temozolomide Accord is used to treat malignant glioma (brain tumours) in the following groups of patients: adults with newly diagnosed glioblastoma multiforme (an aggressive type of brain tumour).
Zdravilo Temozolomide Accord se uporablja za zdravljenje malignih gliomov (možganskih tumorjev) pri naslednjih skupinah bolnikov: odraslih z novo diagnosticiranim multiformnim glioblastomom (vrsto zelo agresivnega možganskega tumorja).
Temozolomide Accord should only be prescribed by physicians experienced in the oncological treatment of brain tumours.
Zdravilo Temozolomid Accord smejo predpisati le zdravniki, ki imajo izkušnje z onkološkim zdravljenjem možganskih tumorjev.
Temozolomide Accordshould be administered in the fasting state.
Zdravilo Temozolomid Accord je treba jemati na tešče.
Temozolomide Hexal
Temozolomid Hexal
Temozolomide Hexal 100 mg hard capsules Temozolomide
Temozolomid Hexal 100 mg trde kapsule temozolomid
Temozolomide Hexal 140 mg hard capsules Temozolomide
Temozolomid Hexal 140 mg trde kapsule temozolomid
Temozolomide Hexal 180 mg hard capsules Temozolomide
Temozolomid Hexal 180 mg trde kapsule temozolomid
Temozolomide Hexal 20 mg hard capsules Temozolomide
Temozolomid Hexal 20 mg trde kapsule temozolomid
Temozolomide Hexal 250 mg hard capsules Temozolomide
Temozolomid Hexal 250 mg trde kapsule temozolomid
Temozolomide Hexal 5 mg hard capsules Temozolomide
Temozolomid Hexal 5 mg trde kapsule temozolomid
Temozolomide Hexal is a ‘generic medicine’.
Temozolomide Hexal je „generično zdravilo“.
Temozolomide Hexal is indicated for the treatment of: adult patients with newly-diagnosed glioblastoma multiforme concomitantly with radiotherapy (RT) and subsequently as monotherapy treatment, children from the age of three years, adolescents and adult patients with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.
Zdravilo Temozolomid Hexal je indicirano za zdravljenje: odraslih bolnikov z novo diagnosticiranim multiformnim glioblastomom, sočasno z radioterapijo (RT) in pozneje kot monoterapija, otrok, starih 3 leta in več, mladostnikov in odraslih bolnikov z malignim gliomom, na primer multiformnim glioblastomom ali anaplastičnim astrocitomom, ki se po standardnem zdravljenju ponovi ali napreduje.
Temozolomide Hexal is used first with radiotherapy and then on its own; adults and children three years of age and over with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, when the tumour has returned or got worse after standard treatment.
Zdravilo Temozolomide Hexal se najprej uporabi skupaj z radioterapijo, nato pa samostojno; odraslih in otrocih, starejših od treh let, z malignim gliomom, kakršna sta multiformni glioblastom ali anaplastični astrocitom, če se je tumor po standardnem zdravljenju ponovil ali poslabšal.
Temozolomide is a triazene, which undergoes rapid chemical conversion at physiologic pH to the active monomethyl triazenoimidazole carboxamide (MTIC).
Mehanizem delovanjaTemozolomid je triazen, ki se pri fiziološki vrednosti pH hitro kemično pretvori v aktivni monometil triazenoimidazol karboksamid (MTIC).
Temozolomide is a triazene, which undergoes rapid chemical conversion at physiologic pH to the active monomethyl triazenoimidazole carboxamide (MTIC).
Temozolomid je snov iz skupine triazenov, ki se pri fiziološkem pH hitro kemično pretvori v aktivni monometiltriazenoimidazol karboksamid (MTIK).
Temozolomide is a triazene, which undergoes rapid chemical conversion at physiologic pH to the active monomethyl triazenoimidazole carboxamide (MTIC).
Temozolomid je triazen, ki se pri fiziološki vrednosti pH hitro kemijsko pretvori v aktivni monometiltriazenoimidazolkarboksamid (MTIC).
Temozolomide is a triazene, which undergoes rapid chemical conversion at physiologic pH to the active monomethyl triazenoimidazole carboxamide (MTIC).
TMZ je triazen, ki se pri fiziološki vrednosti pH hitro kemijsko pretvori v aktivni monometiltriazenoimidazolkarboksamid (MTIC).
Temozolomide monotherapy in recurrent or progressive glioma
Samostojno zdravljenje s tomozolomidom pri ponavljajočem se napredujočem gliomu
Temozolomide Sandoz
Temozolomid Sandoz
Temozolomide Sandoz 100 mg capsules Temozolomide
Temozolomid Sandoz 100 mg trde kapsule temozolomid
Temozolomide Sandoz 100 mg hard capsules Temozolomide
Temozolomid Sandoz 100 mg trde kapsule temozolomid
Temozolomide Sandoz 140 mg capsules Temozolomide
Temozolomid Sandoz 140 mg trde kapsule temozolomid
Temozolomide Sandoz 140 mg hard capsules Temozolomide
Temozolomid Sandoz 140 mg trde kapsule temozolomid
Temozolomide Sandoz 180 mg capsules Temozolomide
Temozolomid Sandoz 180 mg trde kapsule temozolomid
Temozolomide Sandoz 180 mg hard capsules Temozolomide
Temozolomid Sandoz 180 mg trde kapsule temozolomid
Temozolomide Sandoz 20 mg capsules Temozolomide
Temozolomid Sandoz 20 mg trde kapsule temozolomid
Temozolomide Sandoz 20 mg hard capsules Temozolomide
Temozolomid Sandoz 20 mg trde kapsule temozolomid
Temozolomide Sandoz 250 mg capsules Temozolomide
Temozolomid Sandoz 250 mg trde kapsule temozolomid
Temozolomide Sandoz 250 mg hard capsules Temozolomide
Temozolomid Sandoz 250 mg trde kapsule temozolomid
Temozolomide Sandoz 5 mg capsules Temozolomide
Temozolomid Sandoz 5 mg trde kapsule temozolomid
Temozolomide Sandoz 5 mg hard capsules Temozolomide
Temozolomid Sandoz 5 mg trde kapsule temozolomid